Table 2.

Comparison of final disease status with gold standard as histopathology or negative colposcopy for various primary and secondary screening tests

Screening tests	Benign	CIN I	≥CIN II	Total
VIA
Positive	175 (76.4%)	45 (19.7%)	9 (3.9%)	229
Cytology
Negative	156 (78.79%)	40 (20.20%)	2 (1.01%)	198 (86.46%)
Positive	19 (61%)	5 (16%)	7 (23%)	31 (13.54%)
HPV HC2 test
Negative	161 (78.5%)	42 (20.5%)	2 (1.0%)	205 (89.52%)
Positive	14 (58%)	3 (13%)	7 (29%)	24 (10.48%)

VIA=Visual inspection after application of 3-5% acetic acid; CIN=Cervical intraepithelial neoplasia; HPV HC2=Human papillomavirus hybrid capture 2 test